SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.741
EU - Europa 2.708
AS - Asia 2.049
SA - Sud America 64
OC - Oceania 7
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.696
CN - Cina 998
UA - Ucraina 707
DE - Germania 606
SG - Singapore 499
IT - Italia 419
TR - Turchia 419
GB - Regno Unito 296
SE - Svezia 217
FI - Finlandia 159
PL - Polonia 91
BR - Brasile 59
BE - Belgio 47
HK - Hong Kong 41
CA - Canada 40
ID - Indonesia 35
FR - Francia 32
RU - Federazione Russa 32
CZ - Repubblica Ceca 30
NL - Olanda 26
IN - India 15
VN - Vietnam 12
IR - Iran 10
LT - Lituania 10
AT - Austria 6
IE - Irlanda 6
JP - Giappone 6
AU - Australia 4
CH - Svizzera 4
EU - Europa 4
MX - Messico 4
PT - Portogallo 4
TW - Taiwan 4
BG - Bulgaria 3
MA - Marocco 3
NZ - Nuova Zelanda 3
RO - Romania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
JM - Giamaica 1
KR - Corea 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
Totale 14.580
Salva come PNG Salva come JPEG
Città #
Fairfield 1.044
Woodbridge 1.044
Chandler 780
Jacksonville 773
Houston 756
Ann Arbor 622
Santa Clara 564
Ashburn 549
Seattle 428
Wilmington 406
Cambridge 378
Singapore 371
Izmir 257
Nanjing 242
Boardman 178
Princeton 171
Beijing 144
Ferrara 134
New York 130
San Diego 107
Warsaw 90
Milan 83
Shanghai 71
Nanchang 69
Shenyang 68
Dearborn 63
Bremen 62
Hebei 57
Tianjin 47
San Mateo 45
Brussels 44
Düsseldorf 44
Jiaxing 44
Los Angeles 42
Munich 41
Changsha 40
Falls Church 38
Hong Kong 36
Jakarta 35
London 34
Jinan 32
Kunming 30
Addison 28
Norwalk 28
Redwood City 28
Brno 27
Falkenstein 23
Auburn Hills 22
Toronto 22
Helsinki 20
Des Moines 19
Mountain View 19
Zhengzhou 18
Rome 17
Frankfurt am Main 15
Guangzhou 15
Ningbo 15
Augusta 13
Dong Ket 12
Mcallen 12
Orange 12
Washington 12
Hangzhou 11
Philadelphia 11
Taizhou 11
Indiana 10
Verona 10
Ottawa 9
Leawood 8
Montréal 8
Ardabil 7
Florence 7
Haikou 7
Lanzhou 7
Monmouth Junction 7
Nuremberg 7
Padova 7
Amsterdam 6
Hounslow 6
Redmond 6
Bologna 5
Fuzhou 5
Taiyuan 5
Castelcovati 4
Changchun 4
Hanover 4
Hefei 4
Nutley 4
Pune 4
Sala 4
Shenzhen 4
São Paulo 4
Tappahannock 4
Dublin 3
Guarulhos 3
Itajaí 3
Lusia 3
Mülheim-kärlich 3
Pregassona 3
Tashkent 3
Totale 10.791
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 201
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 198
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 159
Hemostasis biomarkers in multiple sclerosis 153
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 151
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 149
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 147
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 141
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 134
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 133
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 131
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 129
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 129
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 128
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 127
Taqi polymorphism at the human coagulation factor XII locus (F12) 125
null 125
Plasma levels of soluble NCAM in multiple sclerosis 125
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 124
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 123
null 121
Membrane binding and anticoagulant properties of protein S natural variants 120
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 119
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 118
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 118
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 118
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 118
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 118
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 117
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 116
Detection and characterization of polymorphic markers in the factor-VII gene. 114
Partial gene deletion in a family with factor X deficiency 114
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 113
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 113
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 112
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 112
Factor VII mutant V154G models a zymogen-like form of factor VIIa 111
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 110
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 109
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 108
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 107
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 107
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 107
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 106
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 106
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 105
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. 105
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 105
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 104
Clinical picture and management of congenital factor VII deficiency 103
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 102
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 102
Risks factors for highly unstable response to oral anticoagulation: a case-control study 101
null 100
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 100
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 99
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 99
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 98
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 98
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 97
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 97
null 96
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 96
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 96
null 96
null 95
2 TAQI RFLPS IN THE HUMAN VONWILLEBRAND-FACTOR GENE 95
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 95
Protein S mRNA in patients with protein S deficiency. 94
null 94
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 93
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 93
c-myc oncogene alterations in human thyroid carcinomas. 93
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 92
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 91
Modulation of thrombophilia genes by environmental factors 88
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region 88
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 86
null 86
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 86
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 86
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 86
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 86
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 86
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 86
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 85
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 85
2 ADDITIONAL TAQI RFLPS IN VONWILLEBRAND-FACTOR GENE (VWF) AND PSEUDOGENE 85
Molecular genetics and biology of congenital hemorrhagic diseases 84
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 84
alpha-Thalassemia trait in the region of Ferrara. 84
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 83
Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. 83
Localization of cloned human DNA sequences and analysis of chromosomal alterations by in situ hybridization. 83
Molecular Characteristics of a Non-deletion α-Thalassaemia of the Po River Delta 83
null 82
Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma 81
Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys→Phe substitution in the second zinc finger of the androgen receptor 80
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 79
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 78
Totale 10.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 625
Totale 74.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020998 0 0 0 0 0 0 0 285 206 341 103 63
2020/20212.223 195 189 148 252 64 202 118 243 58 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20251.469 93 66 295 99 468 299 78 71 0 0 0 0
Totale 14.784